Health Coverage for IVF Act of 2024

Section 1302(b) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(b)) is amended—

(1) in paragraph (1)—

(A) in the matter preceding subparagraph (A), by striking paragraph (2) and inserting paragraphs (2) and (6); and

(B) by adding at the end the following new subparagraph:

(K) Fertility treatment and care.

(B) ; and

(2) by adding at the end the following new paragraph:

For purposes of paragraph (1)(K), the term fertility treatment and care means the following medically appropriate items and services furnished to an individual regardless of whether such individual has a diagnosis of infertility:

(A) Preservation of human oocytes, sperm, or embryos for later reproductive use.

(B) Artificial insemination, including intravaginal insemination, intracervical insemination, and intrauterine insemination.

(C) Assisted reproductive technology, including in vitro fertilization and other treatments or procedures in which reproductive genetic material, such as oocytes, sperm, fertilized eggs, and embryos, are handled, when clinically appropriate.

(D) Genetic testing of embryos.

(E) Medications prescribed or obtained over-the-counter, as indicated for fertility.

(F) Gamete donation.

(G) Such other information, referrals, treatments, procedures, medications, laboratory testing, technologies, and services relating to fertility as the Secretary determines appropriate.

The amendments made by subsection (a) shall apply to plan years beginning on or after the date that is 1 year after the date of the enactment of this Act.